Switch to:
More From Other Websites
Regeneron, Sanofi Look To Crush Amgen, And Rivals Say They Can Mar 23 2017
Alnylam's LDL-Lowering Drug Positive in Phase II Study Mar 20 2017
Esperion And Medicines Co. Recover From Amgen-Induced Pitfall Mar 20 2017
How to Trade the Week's Most Active Stocks--Rite Aid, Amgen, MuleSoft and More Mar 17 2017
MEDICINES CO /DE Files SEC form 8-K, Other Events Mar 17 2017
The Biggest Loser: Amgen Drops 6.4% Mar 17 2017
Esperion's Dive On Amgen Heart Study 'Counterintuitive' On Pricing Mar 17 2017
Amgen Tanks On Heart Study; Shares Of Other Drugmakers Tumble Mar 17 2017
Alnylam touts latest trial data as suggesting its drugs are safe Mar 17 2017
Amgen, Esperion, AmTrust Financial and More: What is Going On With These Falling Stocks? Mar 17 2017
Amgen Blew It…For Medicines Co., Esperion Too Mar 17 2017
The Medicines Company and Alnylam Pharmaceuticals Report Positive Final Results from ORION-1 Phase... Mar 17 2017
[video]AveXis, Esperion and Amgen Among Biotech Movers Mar 17 2017
Amgen Could Boost Rivals On Positive Heart-Disease Study: Analyst Mar 14 2017
The Medicines Company to Webcast Presentation of ORION-1 Phase II Study of Inclisiran at ACC.17 Mar 14 2017
MEDICINES CO /DE Financials Mar 07 2017
The Medicines Company to Host Conference Call and Webcast at Upcoming American College of... Mar 06 2017
The Medicines Co. :MDCO-US: Earnings Analysis: 2016 By the Numbers : March 2, 2017 Mar 02 2017
Medicines Company (MDCO) Q4 Loss Narrower than Expected Mar 01 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK